Eva Vedder

My academic background is in Biopharmaceutical Sciences, in which I obtained both my Bachelors and Master’s degrees, specializing in immunology and oncology. Driven by my interest in immunotherapy, I joined the group of John Haanen in September 2023 as a research technician. Building on this experience, I started my PhD in this group in January 2025. My research focuses on T-cell-based therapies, particularly the optimization and development of tumor-infiltrating lymphocyte (TIL) therapy.